Friday, March 24, 2023
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Teva shareholders may sue over EU Copaxone affair

by Nitsan Shafir
October 22, 2022
in Business
Reading Time: 2 mins read
A A
0
Home Business
Share on FacebookShare on Twitter

Shareholders in Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) filed four petitions for discovery of documents in the Tel Aviv District Court last week, for the purposes of a derivative action against the company. This follows the publication of initial findings of an antitrust investigation by the EU Commission.

In a letter from the Commission to Teva, the company is alleged to have violated EU antitrust laws in practices delaying competition for its multiple sclerosis treatment Copaxone. Among other things, the European Commission alleges that Teva artificially extended Copaxone’s patent and distributed misleading data about rival products.

Some of the shareholders who have petitioned the court claim that company officers at Teva are responsible for the violations and have a fiduciary duty of care under the law.

“The facts detailed below represent an indication that senior people at Teva acted unlawfully, in a way seen to be manipulative and deliberate, and likely to cause severe damage to the company, or at least were severely negligent,” the petition from Lightcom (Israel) Ltd. and Revital Strugano, filed through Advs. Shachar Ben Meir, Renan Gersht, Ophir Naor, Adi Granot, and Yitzhak Aviram, states.

The shareholders are requesting that Teva should discover documents relating to the EU Commission investigation and to the extension of the patent on Copaxone for the purposes of filing a derivative action, a procedure whereby, when the directors of a company fail to sue company officers for damage to the company, shareholders can act. If the claims in a derivative action are upheld, any compensation is paid to the company.

Copaxone is the most widely used treatment for multiple sclerosis, and was Teva’s flagship product for years. In recent years, its contribution to Teva’s profits has declined substantially, as generic competition entered the market. Whereas in 2014 Copaxone accounted for 21% of Teva’s revenue, by 2019 the proportion had fallen to 6%.

Following the announcement by the EU Commission, Teva said in a statement: “We regret that the EU Commission has decided to continue with the investigation of Teva. The Commission’s declaration is a disappointment to Teva, which cooperated intensively with the Commission from the moment that it learned of the investigation in 2019. Teva will defend itself vigorously, and continues its discussions with the Commission to resolve the matter. Teva remains committed to the legal conduct of our business and to the mission of providing accessibility to medicines for millions of people.”

In response to the court petition filed by shareholders for the discovery of documents, Teva stated: “Teva will respond through the accepted channels in the court after the requests are submitted to Teva.”

Published by Globes, Israel business news – en.globes.co.il – on October 20, 2022.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.




Source link

Tags: AffairCopaxoneshareholdersSueTeva
Previous Post

Snap slides 17% as Q3 revenues miss lowered bar (NYSE:SNAP)

Next Post

Your adblocker could be facing a potentially big traffic problem

Related Posts

FPIs Stay Net Sellers For The Second Straight Day

by Vivek Punj
March 24, 2023
0

After a brief respite earlier this week, foreign investors remained net sellers on Friday, for the second day in a...

Viacom18 bags media rights of MotoGP in India

by Euro Times
March 24, 2023
0

Viacom18 on Friday said it has secured exclusive MotoGP rights for India. It said MotoGP will be exclusively live-streamed on...

Finance Bill: How will new Mutual Fund rules impact investors from April 1?

by Euro Times
March 24, 2023
0

The Centre is reportedly introducing an amendment to the mutual fund rules in the...

Commodity Talk: Brent crude may fall to $68 in near term amid supply glut, weak demand

by Euro Times
March 24, 2023
0

Crude prices are in a downtrend and we believe that the US WTI could test $60-$65 levels. As for Brent,...

California ‘price gouging’ bill rushes through state Senate, moves to Assembly

by Euro Times
March 24, 2023
0

JJ Gouin/iStock via Getty Images California moved a step closer Thursday to enacting first-of-its-kind legislation that would penalize oil companies...

Exclusive-N. American fixed income group will not take legal action over Credit Suisse AT1 wipeout -source By Reuters

by Reuters
March 23, 2023
0

© Reuters. FILE PHOTO: A person walks past the Credit Suisse office in Canary Wharf in London, Britain, March 20,...

Next Post

Your adblocker could be facing a potentially big traffic problem

XRP Price Rejected At $0.48, What's Next For XRP?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

EXCLUSIVE: Micki Witthoeft Met with Speaker McCarthy on Thursday for the First Time Since Her Daughter Ashli Babbitt’s Death – Here Is What She Told Us

March 24, 2023

Siemens Healthineers Stock: Undervalued Quality, To Some Degree (OTCMKTS:SEMHF)

March 24, 2023

FPIs Stay Net Sellers For The Second Straight Day

March 24, 2023

Ford announces next-gen EV pickup coming in 2025 By Investing.com

March 24, 2023

KB Home (KBH) Earnings: 1Q23 Key Numbers

March 24, 2023

EU leaders grapple with bank risks as economy weakens

March 24, 2023
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

EXCLUSIVE: Micki Witthoeft Met with Speaker McCarthy on Thursday for the First Time Since Her Daughter Ashli Babbitt’s Death – Here Is What She Told Us

Siemens Healthineers Stock: Undervalued Quality, To Some Degree (OTCMKTS:SEMHF)

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In